TCT 494: Impact of Access in Mortality in Patients Undergoing TAVI: Insights From a Nationwide Registry
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker’s Bureau - Medtronic; Abbott